• Health & Medicine

Behind the scenes with the unsung heroes of cancer clinical trials – Part 2

We speak to Susie Brown, Trial Coordinator on the National Lung Matrix Trial, about what her job involves. We speak to Susie Brown, Trial Coordinator on the National Lung Matrix Trial, about what her job involves.

21 May 2017

• Health & Medicine

Behind the scenes with the unsung heroes of cancer clinical trials – Part 1

We speak to Cindy Billingham, lead statistician on the National Lung Matrix Trial, about what her job involves. We speak to Cindy Billingham, lead statistician on the National Lung Matrix Trial, about what her job involves.

20 May 2017

• Health & Medicine
• Policy & Insight

Smokers will spend around £2000 a year on cigarettes as plain, standardised packs come into full force

From today (Saturday), all tobacco products sold in the UK will come in plain standardised packaging. From today (Saturday), all tobacco products sold in the UK will come in plain standardised packaging.

20 May 2017

• Science & Technology

From finding cancers’ paper trail to harnessing the power of the Zika virus – our latest Pioneer Awards

Find out about the pioneering ideas our researchers are putting to the test, from harnessing the power of the Zika virus to finding cancer’s paper trail. Find out about the pioneering ideas our researchers are putting to the test, from harnessing the power of the Zika virus to finding cancer’s paper trail.

19 May 2017

• Science & Technology

Scientists to test Zika virus on brain tumours

In a revolutionary first, Cancer Research UK-funded scientists will test whether the Zika virus can destroy brain tumour cells. In a revolutionary first, Cancer Research UK-funded scientists will test whether the Zika virus can destroy brain tumour cells.

19 May 2017

• Health & Medicine

Targeted drug delays relapse of intermediate-stage lung cancer

A drug holds lung cancer at bay longer after surgery than standard chemotherapy, according to unpublished results of a new trial in China. A drug holds lung cancer at bay longer after surgery than standard chemotherapy, according to unpublished results of a new trial in China.

19 May 2017

• Health & Medicine

Drug improves survival of patients with rare cancer by almost a quarter

Patients who take capecitabine after surgery for bile duct cancer live for almost a year and a half longer than those not given the drug. Patients who take capecitabine after surgery for bile duct cancer live for almost a year and a half longer than those not given the drug.

17 May 2017

• Health & Medicine

Cutting smoking rates could save the NHS £67 million a year

If smoking rates dropped to five per cent in the UK by 2035, the NHS could save £67million in just one year. If smoking rates dropped to five per cent in the UK by 2035, the NHS could save £67million in just one year.

11 May 2017

• Health & Medicine

Prescription history could help GPs diagnose cancer earlier

Scientists are to examine whether identifying patterns in medication given to patients before they develop cancer could improve early diagnosis. Scientists are to examine whether identifying patterns in medication given to patients before they develop cancer could improve early diagnosis.

11 May 2017

• Health & Medicine

Taking a potential new breast cancer treatment from the lab to the clinic

Our research has led to new clinical trials testing a combination of hormone therapies in women with early, double-positive breast cancer. Our research has led to new clinical trials testing a combination of hormone therapies in women with early, double-positive breast cancer.

5 May 2017

• Science & Technology
• Health & Medicine

Experimental blood test predicts advanced prostate cancer outcome

A blood test could help predict which advanced prostate cancer patients are likely to do best when treated with certain targeted treatments. A blood test could help predict which advanced prostate cancer patients are likely to do best when treated with certain targeted treatments.

4 May 2017

• Health & Medicine

Testing a new immunotherapy treatment for neuroblastoma

A researcher explains an early stage clinical trial testing the potential of a new type of immunotherapy to treat neuroblastoma. A researcher explains an early stage clinical trial testing the potential of a new type of immunotherapy to treat neuroblastoma.

3 May 2017